VERACYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.31 USD | -0.87% |
|
-0.72% | -29.81% |
| 04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
| 02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
Chart calendar Veracyte, Inc.
c1a0375aba4aa1dfc80ad91a.d3XF6wVW85ZdY-9s9PBwx7wJOMXNxVYgjxGY8ROMD8U.DzyriVQep9scJYwnhZkVk_9YTY76ihBTwFb7iFTYRIsRR6aaMB--1To2nA~9da1b0d909d85a55c91255392443c86b
Upcoming events on Veracyte, Inc.
Past events on Veracyte, Inc.
| 04/03/2024 14:50 | Raymond James Institutional Investors Conference |
| 22/02/2024 21:30 | Q4 2023 Earnings Call |
| 22/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/01/2024 21:30 | JPMorgan Healthcare Conference |
| 01/12/2023 18:45 | Society of Urologic Oncology Meeting - Poster No - #237 |
| 01/12/2023 17:45 | Society of Urologic Oncology Meeting - Poster No - #219 |
| 01/12/2023 17:45 | Society of Urologic Oncology Meeting - Poster No - #226 |
| 01/12/2023 15:00 | Society of Urologic Oncology Meeting - Poster No - #201 |
| 01/12/2023 15:00 | Society of Urologic Oncology Meeting - Poster No - #214 |
| 01/12/2023 14:00 | Society of Urologic Oncology Meeting - Poster No - #189 |
| 01/12/2023 14:00 | Society of Urologic Oncology Meeting - Poster No - #200 |
| 15/11/2023 20:00 | Stephens Investment Conference - Fireside Chat |
| 07/11/2023 21:30 | Q3 2023 Earnings Call |
| 07/11/2023 21:05 | Q3 2023 Earnings Release |
| 04/11/2023 00:10 | SITC Meeting |
| 03/11/2023 | SITC Meeting - Abstract No - #782-C |
| 03/11/2023 | SITC Meeting - Abstract No - #70 |
| 03/10/2023 22:30 | American Society for Radiation Oncology Meeting - Abstract No: 2825 |
| 03/10/2023 22:30 | American Society for Radiation Oncology Meeting - Abstract No: 2926 |
| 02/10/2023 23:20 | American Society for Radiation Oncology Meeting - Abstract No:159 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 120 120 0.13% | 117 116 1.49% | 220 215 2.27% | 297 291 1.79% | 361 355 1.71% | 398 |
|
EBITDA Million USD | Released Forecast Spread | -11,0 -6,99 -57.46% | -27,4 -26,9 -2.06% | -62,3 -63,1 1.19% | -15,2 -21,8 30.46% | -58,6 -22,5 -160.83% | -3,09 |
|
EBIT Million USD | Released Forecast Spread | -15,1 -11,2 -34.49% | -35,4 -33,0 -7.2% | -81,9 -79,4 -3.11% | -41,1 -47,0 12.67% | -85,8 -56,7 -51.25% | -20,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,6 -9,15 -37.7% | -34,9 -33,1 -5.33% | -81,6 -84,9 3.78% | -36,4 -43,2 15.77% | -76,6 -52,3 -46.49% | -17,0 |
|
Net income Million USD | Released Forecast Spread | -12,6 -9,07 -38.94% | -34,9 -33,0 -5.91% | -75,6 -79,0 4.3% | -36,6 -43,2 15.35% | -74,4 -52,9 -40.53% | -17,9 |
|
EPS USD | Released Forecast Spread | -0,27 -0,20 -35% | -0,66 -0,63 -4.1% | -1,11 -1,16 3.96% | -0,51 -0,60 15.28% | -1,02 -0,73 -40.05% | -0,24 |
| Announcement Date | 25/02/20 | 17/02/21 | 28/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 67,3 62,5 7.73% | 67,8 61,9 9.48% | 72,9 68,1 7.02% | 75,6 66,4 13.83% | 80,3 74,9 7.18% | 82,4 75,7 8.81% | 90,3 83,1 8.71% | 90,1 84,4 6.78% | 98,2 92,8 5.85% | 93,4 | 98,7 | 101 | 105 | 106 |
|
EBITDA Million USD | Released Forecast Spread | -5,93 -11,2 46.92% | -8,69 -15,3 43.13% | -4,24 -9,40 54.88% | -3,36 -10,6 68.34% | 1,14 -4,60 124.7% | -3,83 -0,30 -1176% | -1,19 -3,50 65.94% | -24,4 -1,30 -1778.15% | -29,2 3,00 -1072.37% | |||||
|
EBIT Million USD | Released Forecast Spread | -12,3 -11,7 -5.1% | -15,2 -18,0 15.42% | -10,7 -16,0 32.84% | -9,68 -17,2 43.78% | -5,42 -10,7 49.19% | -10,5 -8,61 -21.91% | -8,05 -11,0 26.88% | -31,7 -10,3 -209.14% | -35,5 -5,98 -493.79% | -10,7 | -3,77 | -1,81 | 0,23 | -1,03 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,3 -14,2 20.27% | -14,5 -18,8 23.1% | -9,65 -15,6 38.2% | -8,88 -16,8 47.31% | -3,44 -10,3 66.45% | -8,09 -9,45 14.37% | -8,28 -11,0 24.56% | -29,8 -11,3 -163.26% | -30,5 -5,97 -410.66% | -10,7 | -3,75 | -1,79 | 0,25 | -1,00 |
|
Net income Million USD | Released Forecast Spread | -10,5 -12,9 18.2% | -14,5 -17,8 18.86% | -9,53 -16,3 41.6% | -8,72 -17,5 50.11% | -3,84 -10,4 63.12% | -8,09 -9,91 18.38% | -8,40 -11,2 25.28% | -29,6 -11,5 -158.63% | -28,3 -6,83 -314.28% | -10,5 | -3,85 | -2,16 | -0,69 | -1,02 |
|
EPS USD | Released Forecast Spread | -0,14 -0,18 20.32% | -0,20 -0,25 20% | -0,13 -0,23 43.97% | -0,12 -0,25 52.76% | -0,05 -0,14 65.28% | -0,11 -0,14 23.61% | -0,12 -0,16 23.41% | -0,41 -0,16 -164.52% | -0,39 -0,09 -317.87% | -0,15 | -0,06 | -0,03 | -0,01 | -0,03 |
| Announcement Date | 28/02/22 | 03/05/22 | 02/08/22 | 02/11/22 | 22/02/23 | 04/05/23 | 08/08/23 | 07/11/23 | 22/02/24 | - | - | - | - | - |
| 01/05/2024 | CAREDX, INC: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 21:05 | VERACYTE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 12/05/2024 | SEEGENE, INC.: Q1 2024 Earnings Release (Projected) |
| 29/07/2024 | VERACYTE, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Veracyte, Inc.
| Today | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 12/04/2024 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 28/02/2024 21:05 | CAREDX, INC: Q4 2023 Earnings Release |
| 28/02/2024 21:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | VERACYTE, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
| 21/02/2024 21:05 | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
| 15/02/2024 | SEEGENE, INC.: Q4 2023 Earnings Release |
| 09/11/2023 | SEEGENE, INC.: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VCYT Stock
- Calendar Veracyte, Inc.
